Journal ArticleOPEN ACCESS

Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis

BMJ Case Reports (2020) 13(7)
DOI: 10.1136/bcr-2020-236815
14Citations
Citations of this article
118Readers
Mendeley users who have this article in their library.

Abstract

We report on a patient with coronavirus disease 2019 (COVID-19) and decompensated cirrhosis who experienced a favourable outcome of severe immune thrombocytopaenic purpura (ITP) after administration of intravenous immunoglobulin and high-dose dexamethasone. The present case suggests that it is reasonable to evoke ITP in case of profound thrombocytopaenia in a patient with COVID-19.

Author supplied keywords

Cite

CITATION STYLE

APA

Artru, F., Alberio, L., Moradpour, D., & Stalder, G. (2020). Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis. BMJ Case Reports, 13(7). https://doi.org/10.1136/bcr-2020-236815

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free